Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

K

KLRA

Kailera Therapeutics Inc

18.11

Aug 04 • 3:59 PM ET +0.79 (4.56%)

18.11

Aftermarket • 4:25 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Mid NASD

Peers: VKTX NAMS MDGL BMRN KRYS RYTM INCY AXSM KROS NBIX

| Held by: VTI IWM VB VBK VXF VTWO IWO SCHA OZEM SBIO

Scroll to Statements

Index	RUT
Market Cap	2.35B
Enterprise Value	2.83B
Income	-
Sales	-
Book/sh	-3.33
Cash/sh	4.01
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	145
IPO	Apr 17, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	4.52
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	9.67
Current Ratio	9.67
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-3.84
EPS next Q	-0.80
EPS this Y	-159.42%
EPS next Y	-6.56%
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	May 26 AMC
EPS/Sales Surpr.	-470867.74% -

Insider Own	31.05%
Insider Trans	103.10%
Inst Own	12.62%
Inst Trans	20.14%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-1.66%
SMA50	-9.51%
SMA200	-13.91%
Trades

Shs Outstand	129.57M
Shs Float	89.33M
Short Float	7.18%
Short Ratio	9.28
Short Interest	6.41M
52W High	28.23 -35.84%
52W Low	16.39 10.49%
Volatility	7.16% 7.75%
ATR (14)	1.35
RSI (14)	45.51
Beta	-
Rel Volume	0.58
Avg Volume	691.30K
Volume	400,518

Perf Week	8.18%
Perf Month	-22.27%
Perf Quarter	-27.82%
Perf Half Y	-
Perf YTD	-30.35%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	42.75
Prev Close	17.32
Price	18.11
Change	4.56%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)